Back to search

Article

Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling

2023-03-20

Abstract excerpt

Minimally invasive technologies for early diagnosis of epithelial ovarian cancer (EOC) remain an unmet clinical need. CA-125, a tumor marker secreted into the circulation, is utilized to monitor treatment response and disease relapse in EOC, but has limited utility in accurately triaging patients with pelvic masses of unknown histology. To address this unmet need, we applied a novel blood-based glycoproteomic plat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
346e2134-fb64-5fea-88d3-2aab5462a86c
DOI
10.1101/2023.03.20.23287422
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profilingDOI 10.1101/2023.03.20.23287422
Select a neighboring publication to make it the new centre.